Acquired Expression of Mutant Mitofusin 2 Causes Progressive Neurodegeneration and Abnormal Behavior
- PMID: 30606759
- PMCID: PMC6391572
- DOI: 10.1523/JNEUROSCI.2139-18.2018
Acquired Expression of Mutant Mitofusin 2 Causes Progressive Neurodegeneration and Abnormal Behavior
Abstract
Neurons have high plasticity in developmental and juvenile stages that decreases in adulthood. Mitochondrial dynamics are highly important in neurons to maintain normal function. To compare dependency on mitochondrial dynamics in juvenile and adult stages, we generated a mouse model capable of selective timing of the expression of a mutant of the mitochondrial fusion factor Mitofusin 2 (MFN2). Mutant expression in the juvenile stage had lethal effects. Contrastingly, abnormalities did not manifest until 150 d after mutant expression during adulthood. After this silent 150 d period, progressive neurodegeneration, abnormal behaviors, and learning and memory deficits similar to those seen in human neurodegenerative diseases were observed. This indicates that abnormal neuronal mitochondrial dynamics seriously affect survival during early life stages and can also significantly damage brain function after maturation. Our findings highlight the need to consider the timing of disease onset in mimicking human neurodegenerative diseases.SIGNIFICANCE STATEMENT To compare the dependency on mitochondrial dynamics in neurons in juvenile and adult stages, we generated a mouse model expressing a mutant of the mitochondrial fusion factor MFN2 in an arbitrary timing. Juvenile expression of the mutant showed acute and severe phenotypes and had lethal effects; however, post-adult expression induced delayed but progressive phenotypes resembling those found in human neurodegenerative diseases. Our results indicate that abnormal neuronal mitochondrial dynamics seriously affect survival during early life stages and can also significantly damage brain function after maturation. This strongly suggests that the timing of expression should be considered when establishing an animal model that closely resembles human neurodegenerative diseases.
Keywords: MFN2; cognitive impairment; hyperactivity; mitochondrial dynamics; progressive neurodegeneration.
Copyright © 2019 the authors 0270-6474/19/391588-17$15.00/0.
Figures
Similar articles
-
Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator.J Pharmacol Exp Ther. 2024 Oct 18;391(2):361-374. doi: 10.1124/jpet.124.002258. J Pharmacol Exp Ther. 2024. PMID: 39284622 Free PMC article.
-
Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.J Pharmacol Exp Ther. 2022 Nov;383(2):137-148. doi: 10.1124/jpet.122.001332. Epub 2022 Sep 2. J Pharmacol Exp Ther. 2022. PMID: 36507849 Free PMC article.
-
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.J Neurol Sci. 2015 Sep 15;356(1-2):7-18. doi: 10.1016/j.jns.2015.05.033. Epub 2015 May 29. J Neurol Sci. 2015. PMID: 26143526 Review.
-
Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model.J Peripher Nerv Syst. 2014 Jun;19(2):152-64. doi: 10.1111/jns5.12066. J Peripher Nerv Syst. 2014. PMID: 24862862
-
Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A.Exp Neurol. 2009 Aug;218(2):268-73. doi: 10.1016/j.expneurol.2009.05.003. Epub 2009 May 8. Exp Neurol. 2009. PMID: 19427854 Review.
Cited by
-
Age-Dependent Behavioral and Metabolic Assessment of App NL-G-F/NL-G-F Knock-in (KI) Mice.Front Mol Neurosci. 2022 Jul 29;15:909989. doi: 10.3389/fnmol.2022.909989. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35966019 Free PMC article.
-
Mitochondrial ubiquitin ligase alleviates Alzheimer's disease pathology via blocking the toxic amyloid-β oligomer generation.Commun Biol. 2021 Feb 12;4(1):192. doi: 10.1038/s42003-021-01720-2. Commun Biol. 2021. PMID: 33580194 Free PMC article.
-
Mitochondrial protein dysfunction in pathogenesis of neurological diseases.Front Mol Neurosci. 2022 Sep 7;15:974480. doi: 10.3389/fnmol.2022.974480. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36157077 Free PMC article. Review.
-
A Novel Interaction between MFN2/Marf and MARK4/PAR-1 Is Implicated in Synaptic Defects and Mitochondrial Dysfunction.eNeuro. 2023 Aug 18;10(8):ENEURO.0409-22.2023. doi: 10.1523/ENEURO.0409-22.2023. Print 2023 Aug. eNeuro. 2023. PMID: 37550059 Free PMC article.
-
Large-scale animal model study uncovers altered brain pH and lactate levels as a transdiagnostic endophenotype of neuropsychiatric disorders involving cognitive impairment.Elife. 2024 Mar 26;12:RP89376. doi: 10.7554/eLife.89376. Elife. 2024. PMID: 38529532 Free PMC article.
References
-
- Ahlemeyer B, Halupczok S, Rodenberg-Frank E, Valerius KP, Baumgart-Vogt E (2018) Endogenous murine amyloid-beta peptide assembles into aggregates in the aged C57BL/6J mouse suggesting these animals as a model to study pathogenesis of amyloid-beta plaque formation. J Alzheimers Dis 61:1425–1450. 10.3233/JAD-170923 - DOI - PubMed
-
- Baek SH, Park SJ, Jeong JI, Kim SH, Han J, Kyung JW, Baik SH, Choi Y, Choi BY, Park JS, Bahn G, Shin JH, Jo DS, Lee JY, Jang CG, Arumugam TV, Kim J, Han JW, Koh JY, Cho DH, Jo DG (2017) Inhibition of Drp1 ameliorates synaptic depression, Aβ deposition, and cognitive impairment in an Alzheimer's disease model. J Neurosci 37:5099–5110. 10.1523/JNEUROSCI.2385-16.2017 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous